XML 144 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Collaboration and License Agreements - Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]    
Revenue $ 3,551 $ 62,546
GSK    
Disaggregation of Revenue [Line Items]    
Revenue 2,685 (677)
Horizon    
Disaggregation of Revenue [Line Items]    
Revenue 0 21,667
Takeda    
Disaggregation of Revenue [Line Items]    
Revenue 866 16,312
Janssen    
Disaggregation of Revenue [Line Items]    
Revenue 0 244
Amgen    
Disaggregation of Revenue [Line Items]    
Revenue $ 0 $ 25,000